Short interruptions of TNF-inhibitor treatment can be associated with treatment failure in patients with immune-mediated diseases

• Ngā kaituhi matua: Tea Lamberg (Author), Taina Sipponen (Author), Sanna Valtanen (Author), Kari K Eklund (Author), Tarja Mälkönen (Author), Kristiina Aalto (Author), Katriina Mikola (Author), Kaija-Leena Kolho (Author), Sanna Leinonen (Author), Pia Isomäki (Author), Heidi Mäkinen (Author), Krista-Liisa Vidqvist (Author), Arto Kokko (Author), Laura Huilaja (Author), Minna Kyllönen (Author), Paula Keskitalo (Author), Sirja Sard (Author), Paula Vähäsalo (Author), Ritva Koskela (Author), Liisa Kröger (Author), Perttu Lahtinen (Author), Anna-Maija Haapala (Author), Katja Korkatti (Author), Tuulikki Sokka-Isler (Author), T. Sakari Jokiranta (Author)
• Hōputu: Pukapuka
• I whakaputaina: Taylor & Francis Group, 2022-07-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Introduction The prevalence of immune-mediated diseases has increased in the past decades and despite the use of biological treatments all patients do not achieve remission. The aim of this study was to characterise the reasons for short interruptions during treatment with two commonly used TNF-inhi...